Manuscripts

Search by keyword, year, or author name.

Showing 1590 manuscripts.

Analyses of HIV-1 drug-resistance profiles among infected adolescents experiencing delayed antiretroviral treatment switch after initial nonsuppressive highly active antiretroviral therapy antiretroviral Therapy.

Allison Agwu, M.D., Jane C. Lindsey, Sc.D., Kimberly Ferguson, Hao Zhang, M.D., Stephen A. Spector, M.D., Bret J. Rudy, M.D., Stuart C. Ray, Steven D. Douglas, M.D., Patricia M. Flynn, M.D., M.S., Deborah Persaud, M.D. Analyses of HIV-1 drug-resistance profiles among infected adolescents experiencing delayed antiretroviral treatment switch after initial nonsuppressive highly active antiretroviral therapy antiretroviral Therapy. AIDS Patient Care and STDs. 2009 Feb 25; 22(7):545-52.

Year

2009

Journal

AIDS Patient Care and STDs

Cryopreservation Decreases PD-1/PD-L1 Co-Inhibitory Expression on PBMC-Derived T Cells and Monocytes

Donald Campbell, Ph.D., Nancy Tustin, M.L.T., (ASCP), Eric Riedel, B.S., Richard Tustin, III, Jonathan Taylor, Ph.D., Steven D. Douglas, M.D., J. Edward Murray. Cryopreservation Decreases PD-1/PD-L1 Co-Inhibitory Expression on PBMC-Derived T Cells and Monocytes. Clinical and Vaccine Immunology. 2009 Nov 01; 16(11):1648-53. PMID: 19726615; PMCID: PMC2772387.

Year

2009

Journal

Clinical and Vaccine Immunology

The role of cognitive functioning in medication adherence of children and adolescents with HIV infection.

Kathleen Malee, Ph.D., Paige L. Williams, Ph.D., Grace Montepiedra, Ph.D., Sharon L. Nichols, Ph.D., Patricia Sirois, Ph.D., Deborah S. Storm, R.N.,Ph.D, John J. Farley, M.D., M.P.H., Betsy Kammerer, Ph.D. The role of cognitive functioning in medication adherence of children and adolescents with HIV infection. Journal of Pediatric Psychology. 2009 Mar 01; 34(2):165-75. PMID: 18647794; PMCID: PMC2722123.

Year

2009

Journal

Journal of Pediatric Psychology

Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance

Christina M. Marra, M.D., Yu Zhao, David B. Clifford, M.D., Scott L. Letendre, M.D., Scott Evans, Ph.D., Kate Henry, Ronald J. Ellis, M.D.,Ph.D., Benigno Rodriguez, M.D., Robert W. Coombs, M.D., Ph.D., Giovanni Schifitto, M.D., Justin C. McArthur, M.B.B.S., M.P.H., Kevin R. Robertson, Ph.D. Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance. AIDS. 2009 May 06; 23(11):1359-66. PMID: 19424052; PMCID: PMC2706549.

Year

2009

Journal

AIDS

Low rate of CMV end-organ disease in HIV-infected patients despite low CD4+ cell counts and CMV viremia: results of ACTG protocol A5030.

David Alain Wohl, M.D., Michelle A. Kendall, M.S., Janet Andersen, Sc.D., Clyde S. Crumpacker, M.D., Stephen A. Spector, M.D., Judith Feinberg, M.D., Beverly L. Alston-Smith, M.D., Susan Owens, R.N., M.S., Suzette A. Chafey, R.N., N.P., Michael Marco, Sharon D. Maxwell-Henkel, B.S., Nell Lurain, Ph.D., Douglas Jabs, M.D., M.B.A., Constance A. Benson, M.D., Philip Keiser, M.D. Low rate of CMV end-organ disease in HIV-infected patients despite low CD4+ cell counts and CMV viremia: results of ACTG protocol A5030. HIV Clinical Trials. 2009 Jun 01; 10(3):143-52. PMID: 19632953; PMCID: PMC2754189.

Year

2009

Journal

HIV Clinical Trials

Long-term impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals (ACTG 5097s)

David B. Clifford, M.D., Scott Evans, Ph.D., Yijun Yang, M.S., Sc.D., Edward P. Acosta, Pharm.D., Heather Ribaudo, Ph.D., Roy (Trip) Gulick, M.D., M.P.H. Long-term impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals (ACTG 5097s). HIV Clinical Trials. 2009 Dec 01; 10(6):343-55.

Year

2009

Journal

HIV Clinical Trials

IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection

Irini Sereti, M.D., Richard Dunham, John Spritzler, Sc.D., Evgenia Aga, M.Sc., Michael Proschan, Ph.D., Kathleen A. Medvik, B.S., M.T. (A.S.C.P.), Cathy Battaglia, M.P.H., C.C.R.P., Alan Landay, Ph.D., Savita G. Pahwa, M.D., Margaret A. Fischl, M.D., David M. Asmuth, M.D., Allan R. Tenorio, M.D., John Altman, Ph.D., Lawrence Fox, M.D., Ph.D., Susan Moir, Angelina Malaspina, Michel Morre, Renaud Buffet, M.D., Guido Silvestri, M.D., Michael M. Lederman, M.D. IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection. Blood. 2009 Jun 18; 113(25):6304-14. PMCID: PMC2710926.

Year

2009

Journal

Blood

A randomized trial of therapeutic drug monitoring of protease inhibitors in antiretroviral-experienced, HIV-1-infected patients

Lisa M. Demeter, M.D., Hongyu Jiang, Ph.D., Lisa Mukherjee, M.S., Gene D. Morse, Pharm.D., Robin DiFrancesco, M.T., (ASCP), M.B.A., Robert DiCenzo, Pharm.D., Carrie Dykes, Ph.D., Prakash Sista, Ph.D., Lee Bacheler, Ph.D., Karin L. Klingman, M.D., Alex R. Rinehart, Ph.D., Mary Albrecht, M.D. A randomized trial of therapeutic drug monitoring of protease inhibitors in antiretroviral-experienced, HIV-1-infected patients. AIDS. 2009 Jan 28; 23(3):357-68. PMCID: PMC2798571.

Year

2009

Journal

AIDS

Acetyl-l-carnitine and nucleoside reverse transcriptase inhibitor-associated neuropathy in HIV infection

Victor G. Valcour, M.D., Tzu-min Yeh, Russell Bartt, M.D., David B. Clifford, M.D., Mariana Gerschenson, Ph.D., Scott Evans, Ph.D., Bruce A. Cohen, M.D., G. J. Ebenezer, M.B.B.S., Peter Hauer, M.D., Linda L. Millar, B.S., Mary Gould, R.N., B.A., Paul T. Tran, R.Ph., Cecilia M. Shikuma, M.D., Scott Souza, Pharm.D., Justin C. McArthur, M.B.B.S., M.P.H. Acetyl-l-carnitine and nucleoside reverse transcriptase inhibitor-associated neuropathy in HIV infection. HIV Medicine. 2009 Feb 01; 10(2):103-110. PMCID: PMC2653263.

Year

2009

Journal

HIV Medicine